Repatha®

By clicking on the above links, you will be leaving our website and Amgen does not endorse or accept liability for sites controlled by third parties

+
Keep up to date with Amgen! Sign up to our mailing list to receive further relevant information, meeting invites and updates by clicking here.

Make Repatha® your PCSK9i of choice

The Repatha® CV Hub has been designed to not only provide you with information on Repatha®, but also to support you as a centralised hub of information where you can access the latest guideline recommendations, expert guidance on LDL-C management and the identification of high-risk CV patients.

Sort By Title
  • Sort By Title
  • Sort By Date
LDL-C | Act now to minimise the risk
Treat early, aim low
The ESC & EAS recommends early intensive LDL-C reduction
LDL-C | Act now to minimise the risk
Familial hypercholesterolaemia
The importance of proactively identifying your patients with FH
LDL-C | Act now to minimise the risk
Expert management
Expert guidance on the management of LDL-C
REPATHA®
About Repatha®
What can Repatha® deliver your patients with high LDL-C?
REPATHA®
Repatha® CV outcomes
How Repatha® can help your patients achieve rapid and sustained CV improvements
REPATHA®
Repatha® LDL-C reductions
How Repatha® can help your patients achieve rapid and sustained LDL-C reductions
REPATHA®
Repatha® dosage & administration
Optimising the dosage and administration of Repatha®
REPATHA®
Repatha® safety & tolerability
A safety profile established in the long-term
REPATHA®
Repatha® patient profiles
Choosing the right patient for Repatha®
SUPPORT | For you & your patients
How Amgen supports you
Access support for you and your patients
SUPPORT | For you & your patients
Amgen CV Academy UK
A platform for HCPs with a special interest in lipid management
SUPPORT | For you & your patients
Case studies
See cardiovascular care in practice
SUPPORT | For you & your patients
Resource centre
Download supporting information on lipid management